Jentadueto
Active substance: linagliptin, metformin
linagliptin, metformin
Centralised EU authorisationActive
Marketing holder: Boehringer Ingelheim International GmbH
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| RU 11 |
|
| US 17 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-2e14-77c2-bd94-484c95b91850,01a120c3-58a8-7062-90fd-70ee6aee5c9a,01a120c3-6a02-7467-bcaf-3f1b2b395a97,01a120c3-8471-7a41-ab0c-71e1ec473d0d,01a120c3-b09b-7ba6-9a15-c41b1440bb47;count=8 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-327a-7a47-a9df-d63d996d0396,01a12093-896e-7115-b264-03c576699e45,01a12098-cd18-7668-88e5-468801b8d6d6;count=3 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- EMEA/H/C/002279
- Registration status
- Active
- ATC code
- A10BD11
- product · EMA · EMEA/H/C/002279 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/002279 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/002279 · Verified 2026-10-09
- ingredients.1 · EMA · EMEA/H/C/002279 · Verified 2026-10-09